Table 4. miRNA expression and survival in non-smoking female lung adenocarcinoma.

miRNAs	group	Number n =105	HR (95% CI)	HR a (95% CI)	Log-rank P
miR-155	LE	52	1.00	1.00	0.533
	HE	53	1.29(0.58-2.89)	1.38(0.61-3.13)
miR-25	LE	53	1.00	1.00	0.160
	HE	52	0.55(0.23-1.29)	0.68(0.28-1.62)
miR-16	LE	52	1.00	1.00	0.184
	HE	53	0.57(0.24-1.33)	0.61(0.26-1.47)
miR-133a	LE	52	1.00	1.00	0.280
	HE	53	1.57(0.69-3.62)	1.86(0.79-4.35)
miR-19a	LE	52	1.00	1.00	0.040
	HE	53	0.41(0.17-0.99)	0.41(0.17-1.00)
miR-19b	LE	52	1.00	1.00	0.095
	HE	53	0.49(0.21-1.16)	0.51(0.22-1.22)
miR-20a	LE	53	1.00	1.00	0.218
	HE	52	0.59(0.25-1.39)	0.68(0.28-1.63)
miR-20b	LE	52	1.00	1.00	0.180
	HE	53	0.56(0.24-1.32)	0.63(0.26-1.51)
miR-629	LE	52	1.00	1.00	0.218
	HE	53	0.60(0.26-1.37)	0.61(0.27-1.39)
miR-451	LE	52	1.00	1.00	0.335
	HE	53	0.67(0.29-1.53)	0.79(0.34-1.86)
miR-192	LE	51	1.00	1.00	0.093
	HE	54	0.49(0.21-1.15)	0.55(0.23-1.31)
miR-195	LE	53	1.00	1.00	0.011
	HE	52	0.30(0.11-0.80)	0.31(0.11-0.83)
miR-122	LE	53	1.00	1.00	0.012
	HE	52	0.33(0.13-0.82)	0.34(0.13-0.88)
miR-106b	LE	53	1.00	1.00	0.090
	HE	52	0.49(0.21-1.14)	0.49(0.20-1.21)
miR-26b	LE	52	1.00	1.00	0.831
	HE	53	0.92(0.41-2.06)	0.98(0.41-2.31)
miR-143	LE	53	1.00	1.00	0.497
	HE	52	1.32(0.59-2.99)	1.29(0.54-3.06)
miR-374	LE	52	1.00	1.00	0.892
	HE	53	1.06(0.47-2.39)	1.03(0.44-2.43)
miR-374-5p	LE	52	1.00	1.00	0.887
		HE	53	0.94(0.42-2.12)	0.92(0.39-2.18)
miR-486-3p	LE	53	1.00	1.00	0.096
	HE	52	0.48(0.20-1.17)	0.55(0.23-1.36)
miR-590-5p	LE	52	1.00	1.00	0.052
	HE	53	0.44(0.19-1.03)	0.43(0.18-1.02)

LE: Low Expression; HE: High Expression. LE and HE were divided by median expression of specific miRNA.

^aadjusted for stage, age and treatment